INVITRO ACTIVITIES OF QUINOLONES AGAINST ENTEROCOCCI RESISTANT TO PENICILLIN-AMINOGLYCOSIDE SYNERGY

[11] EFFECTS OF NOVOBIOCIN, COUMERMYCIN-A1, CLOROBIOCIN, AND THEIR ANALOGS ON ESCHERICHIA-COLI DNA GYRASE AND BACTERIAL-GROWTH [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) : 662 - 671

[12] HIGH-LEVEL, PLASMID-BORNE RESISTANCE TO GENTAMICIN IN STREPTOCOCCUS-FAECALIS SUBSP ZYMOGENES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) : 686 - 689

[13] USE OF STREPTOMYCIN IN THE TREATMENT OF BACTERIAL ENDOCARDITIS [J]. AMERICAN JOURNAL OF MEDICINE, 1947, 2 (05) : 436 - 442

[14] BETA-LACTAMASE PRODUCTION IN EXPERIMENTAL ENDOCARDITIS DUE TO AMINOGLYCOSIDE-RESISTANT STREPTOCOCCUS-FAECALIS [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) : 1226 - 1232

[15] IDENTIFICATION OF STREPTOCOCCUS-FAECALIS AND STREPTOCOCCUS-FAECIUM AND SUSCEPTIBILITY STUDIES WITH NEWLY DEVELOPED ANTIMICROBIAL AGENTS [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (05) : 787 - 790

[16] THE INVITRO ACTIVITY OF CI-934 COMPARED WITH THAT OF OTHER NEW 4-QUINOLONES AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 163 - 169

[17] ENTEROCOCCAL ENDOCARDITIS . AN ANALYSIS OF 38 PATIENTS OBSERVED AT NEW YORK HOSPITAL-CORNELL MEDICAL CENTER [J]. ARCHIVES OF INTERNAL MEDICINE, 1970, 125 (02) : 258 - &

[18] INVITRO ACTIVITY OF CI-934, A NEW QUINOLONE, COMPARED WITH THAT OF OTHER QUINOLONES AND OTHER ANTIMICROBIAL AGENTS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) : 852 - 857

[19] HIGH-LEVEL RESISTANCE TO GENTAMICIN IN CLINICAL ISOLATES OF ENTEROCOCCI [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (04) : 751 - 757

[20] Moellering R C Jr, 1970, Antimicrob Agents Chemother (Bethesda), V10, P335

[11] EFFECTS OF NOVOBIOCIN, COUMERMYCIN-A1, CLOROBIOCIN, AND THEIR ANALOGS ON ESCHERICHIA-COLI DNA GYRASE AND BACTERIAL-GROWTH [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) : 662 - 671

[12] HIGH-LEVEL, PLASMID-BORNE RESISTANCE TO GENTAMICIN IN STREPTOCOCCUS-FAECALIS SUBSP ZYMOGENES [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (05) : 686 - 689

[13] USE OF STREPTOMYCIN IN THE TREATMENT OF BACTERIAL ENDOCARDITIS [J]. AMERICAN JOURNAL OF MEDICINE, 1947, 2 (05) : 436 - 442

[14] BETA-LACTAMASE PRODUCTION IN EXPERIMENTAL ENDOCARDITIS DUE TO AMINOGLYCOSIDE-RESISTANT STREPTOCOCCUS-FAECALIS [J]. JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) : 1226 - 1232

[15] IDENTIFICATION OF STREPTOCOCCUS-FAECALIS AND STREPTOCOCCUS-FAECIUM AND SUSCEPTIBILITY STUDIES WITH NEWLY DEVELOPED ANTIMICROBIAL AGENTS [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (05) : 787 - 790

[16] THE INVITRO ACTIVITY OF CI-934 COMPARED WITH THAT OF OTHER NEW 4-QUINOLONES AND NALIDIXIC-ACID [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 163 - 169

[17] ENTEROCOCCAL ENDOCARDITIS . AN ANALYSIS OF 38 PATIENTS OBSERVED AT NEW YORK HOSPITAL-CORNELL MEDICAL CENTER [J]. ARCHIVES OF INTERNAL MEDICINE, 1970, 125 (02) : 258 - &

[18] INVITRO ACTIVITY OF CI-934, A NEW QUINOLONE, COMPARED WITH THAT OF OTHER QUINOLONES AND OTHER ANTIMICROBIAL AGENTS [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) : 852 - 857

[19] HIGH-LEVEL RESISTANCE TO GENTAMICIN IN CLINICAL ISOLATES OF ENTEROCOCCI [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (04) : 751 - 757

[20] Moellering R C Jr, 1970, Antimicrob Agents Chemother (Bethesda), V10, P335